Stock CIPLA CIPLA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Cipla Limited

Equities

CIPLA

INE059A01026

Delayed NSE India S.E.
Other stock markets
 04:09:58 2024-04-26 am EDT 		5-day change 1st Jan Change
1,410 INR +0.26% Intraday chart for Cipla Limited +4.74% +13.10%
Apr. 24 Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides MT
Apr. 19 Cipla Limited Receives Order from the GST Authority CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Indian Equities End Higher Midweek as Iran-Israel Conflict Subsides
MT
Cipla Limited Receives Order from the GST Authority
CI
India's Biocon developing its own version of Wegovy, clinical trial likely next year
RE
Cipla's Consumer Healthcare Arm to Acquire Ivia's Cosmetics, Personal-Care Marketing Business
MT
Indian Equities End Higher on Wednesday, Lifted Mainly by Metal Stocks
MT
Cipla Receives US FDA Observations Following Patalganga Facility Inspection
MT
Cipla Gets Regulatory Nod to Merge US-Based Subsidiaries
MT
Cipla to Distribute Sanofi's CNS Product Line in India
MT
Cipla Limited Appoints Rajeev Kumar Sinha as Senior Management Personnel and Global Chief Manufacturing Officer, Effective April 1, 2024
CI
Cipla : Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in India
PU
Sanofi India Limited, Sanofi Healthcare India Private Limited and Cipla Limited Announce an Exclusive Partnership
CI
Losses Led by IT Drag Indian Equities on Tuesday
MT
Cipla Limited Appoints Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain, Effective from 1 April 2024
CI
Indian Equities Close with Marginal Gains on Tuesday as IT Stocks See Drop
MT
Cipla Arm Completes Sale of Entire Stake in Wellthy
MT
India pharma companies develop versions of Wegovy to get in on weight-loss windfall
RE
Indian Equities Close Higher Midweek, Led by Banking, IT Stocks
MT
Indian drugmaker Lupin beats quarterly profit estimates on strong demand
RE
Indian drugmaker J B Chemicals posts Q3 profit rise on strong demand
RE
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CIPLA Stock
  4. News Cipla Limited